Learn more

SHANGHAI LONGWOOD BIOPHARMACEUTICALS CO LTD

Overview
  • Total Patents
    36
  • GoodIP Patent Rank
    43,047
  • Filing trend
    ⇧ 233.0%
About

SHANGHAI LONGWOOD BIOPHARMACEUTICALS CO LTD has a total of 36 patent applications. It increased the IP activity by 233.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are DART NEUROSCIENCE (CAYMAN) LTD, INFINITY DISCOVERY INC and PYRAMID BIOSCIENCES INC.

Patent filings per year

Chart showing SHANGHAI LONGWOOD BIOPHARMACEUTICALS CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Wang Zhe 36
#2 Zeng Zhihong 24
#3 Yang Sai 14
#4 Fan Guoqin 13
#5 Wang Xiaoguang 13
#6 Lu Cenbin 7
#7 Qian Anran 4
#8 Li Deliang 4
#9 Jiang Rongzhen 2
#10 Bai Haiyun 2

Latest patents

Publication Filing date Title
WO2021047547A1 Novel tricyclic aromatic heterocyclic compound, preparation method therefor, pharmaceutical composition and application thereof
WO2021047555A1 Preparation of aromatic heterocyclic derivative as immunomodulator and application thereof
WO2021047556A1 Nitrogen-containing heterocyclic compound, and preparation method therefor, pharmaceutical composition comprising same and use thereof
WO2021047553A1 Aromatic heterocyclic compound having tricyclic structure, and preparation method therefor and application thereof
US2020354366A1 Bicyclic nucleocapsid inhibitor and use of same as drug in treatment of hepatitis b
CN110437232A Double and ring ureas nucleocapsid inhibitor and its medicinal usage
CN110437132A Double and heterocyclic nucleus capsid inhibitor and its medicinal usage
CN108456216A Sulfonyl hydrazines compound and application thereof
WO2018133875A1 Jak kinase inhibitor and preparation method and use thereof